Skip to main content

Advertisement

SpringerLink
Log in

Beryllium exposure: dermal and immunological considerations

  • Short Communication
  • Published:
International Archives of Occupational and Environmental Health Aims and scope Submit manuscript

Abstract

Objective: People exposed to beryllium compounds are at increased risk of developing beryllium sensitization and chronic beryllium disease (CBD). The purpose of this short communication is to present information regarding the potential importance of skin exposure to beryllium, an exposure and alternate immune response pathway to the respiratory tract, which has been largely overlooked in epidemiologic and exposure assessment studies. Methods: We reviewed the published literature, including epidemiologic, immunologic, genetic, and laboratory-based studies of in vivo and in vitro models, to assess the state of knowledge concerning skin exposure to beryllium. Results: Reduction in inhalation exposure to beryllium has not resulted in a concomitant reduction in the occurrence of beryllium sensitization or CBD, suggesting that continued prevalence may be due, in part, to unchecked skin exposure to beryllium-containing particles. Conclusions: Recent developments in our understanding of the multiple exposure pathways that may lead to beryllium sensitization and CBD suggest that a prudent approach to worker protection is to assess and minimize both skin and inhalation exposures to beryllium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Abbas AK, Lichtman AH, Pober JS (2000) Cellular and molecular immunology. Saunders, Philadelphia

    Google Scholar 

  • Apostoli P, Schaller KH (2001) Urinary beryllium—a suitable tool for assessing occupational and environmental beryllium exposure? Int Arch Occup Environ Health 74:162–166

    Article  PubMed  CAS  Google Scholar 

  • Curtis GH (1951) Cutaneous hypersensitivity due to beryllium: a study of thirteen cases. Arch Dermat Syphilol 64:470–482

    CAS  Google Scholar 

  • Day GA, Hoover MD, Stefaniak AB, Dickerson RM, Peterson EJ, Esmen NA, Scripsick RC (2005) Bioavailability of beryllium oxide particles: an in vitro study in murine macrophages. Exp Lung Res 31:341–360

    Article  PubMed  CAS  Google Scholar 

  • DeNardi JM, VanOrdstrand HS, Curtis GH, Zielinski J (1953) Berylliosis: summary and survey of all clinical types observed in a twelve-year period. AMA Arch Ind Hyg Occup Med 8:1–24

    CAS  Google Scholar 

  • Deubner DC, Goodman M, Iannuzzi J (2001) Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce study. Appl Occup Environ Hyg 16:521–526

    Article  PubMed  CAS  Google Scholar 

  • Eidson AF, Taya A, Finch GL, Hoover MD, Cook C (1991) Dosimetry of beryllium in cultured canine pulmonary alveolar macrophages. J Toxicol Environ Health 34:433–448

    Article  PubMed  CAS  Google Scholar 

  • Eisenbud M (1998) The standard for control of chronic beryllium disease. Appl Occup Environ Hyg 13:25–31

    CAS  Google Scholar 

  • Finch GL, Mewhinney JA, Eidson AF, Hoover MD, Rothenberg SJ (1988) In vitro dissolution characteristics of beryllium oxide and beryllium metal aerosols. J Aerosol Sci 19:333–342

    Article  CAS  Google Scholar 

  • Fontenot AP, Kotzin BL, Comment CE, Newman LS (1998) Expansions of T-cell subsets expressing particular receptor variable regions in chronic beryllium disease. Am J Respir Cell Mol Biol 18:581–589

    PubMed  CAS  Google Scholar 

  • Henneberger PK, Cumro D, Deubner DD, Kent MS, McCawley M, Kreiss K (2001) Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health 74:167–176

    Article  PubMed  CAS  Google Scholar 

  • Henneberger PK, Goe SK, Miller WE, Doney B, Groce DW (2004) Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed. J Occup Environ Hyg 1:648–659

    Article  PubMed  CAS  Google Scholar 

  • Klemperer FW, Martin AP, Van Riper J (1951) Beryllium excretion in humans. AMA Arch Ind Hyg Occup Med 4:251–256

    CAS  Google Scholar 

  • Kolanz M (2001) Introduction to beryllium: uses, regulatory history, and disease. Appl Occup Environ Hyg J 16:559–567

    Article  CAS  Google Scholar 

  • Kreiss K, Newman LS, Mroz MM, Campbell PA (1989) Screening blood test identifies subclinical beryllium disease. J Occup Med 31:603–608

    Article  PubMed  CAS  Google Scholar 

  • Kreiss K, Mroz MM, Zhen B, Martyny JW, Newman LS (1993a) Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis 148:985–991

    PubMed  CAS  Google Scholar 

  • Kreiss K, Wasserman S, Mroz MM, Newman LS (1993b) Beryllium disease screening in the ceramics industry: blood lymphocyte test performance and exposure-disease relations. J Occup Med 35:267–274

    PubMed  CAS  Google Scholar 

  • Kreiss K, Mroz MM, Newman LS, Martyny J, Zhen B (1996) Machining risk of beryllium disease and sensitization with median exposures below 2 μg/m3. Am J Ind Med 30:16–25

    Article  PubMed  CAS  Google Scholar 

  • Kreiss K, Mroz MM, Zhen B, Wiedemann H, Barna BP (1997) Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med 54:605–612

    Article  PubMed  CAS  Google Scholar 

  • Newman LS, Mroz MM, Balkissoon R, Maier LA (2005) Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med 171:54–60

    Article  PubMed  Google Scholar 

  • Rossman MD (2001) Chronic beryllium disease: a hypersensitivity disorder. Appl Occup Environ Hyg 16:615–618

    Article  PubMed  CAS  Google Scholar 

  • Sackett HM, Maier LA, Silveira LJ, Mroz MM, Ogden LG, Murphy JR, Newman LS (2004) Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations. J Occup Environ Med 46:953–961

    Article  PubMed  CAS  Google Scholar 

  • Saltini CS, Winestock K, Kirby BA, Pinkston P, Crystal RG (1989) Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med 320:1103–1109

    Article  PubMed  CAS  Google Scholar 

  • Saltini C, Richeldi L, Losi M, Amicosante M, Voorter C, van den Berg-Loonen E, Dweik RA, Wiedemann HP, Deubner DC, Tinelli C (2001) Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur Respir J 18:677–684

    Article  PubMed  CAS  Google Scholar 

  • Schuler CR, Kent MS, Deubner DC, Berakis MT, McCawley M, Henneberger PK, Rossman MD, Kreiss K (2005) Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med 47:195–205

    Article  PubMed  CAS  Google Scholar 

  • Snyder JA, Weston A, Tinkle SS, Demchuk E (2003) Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease. Environ Health Perspect 111:1827–1834

    PubMed  CAS  Google Scholar 

  • Stange AW, Furman FJ, Hilmas DE (2004) The beryllium lymphocyte proliferation test: relevant issues in beryllium health surveillance. Am J Ind Med 46:453–462

    Article  PubMed  Google Scholar 

  • Stefaniak AB, Hoover MD, Dickerson RM, Peterson EJ, Day GA, Breysse PN, Kent MS, Scripsick RC (2003) Surface area of respirable beryllium metal, oxide, and copper alloy aerosols and implications for assessment of exposure risk of chronic beryllium disease. Am Ind Hyg Assoc J 64:297–305

    CAS  Google Scholar 

  • Stefaniak AB, Hoover MD, Day GA, Dickerson RM, Peterson EJ, Kent MS, Schuler CR, Breysse PN, Scripsick RC (2004) Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease. J Environ Monit 6:523–532

    Article  PubMed  CAS  Google Scholar 

  • Stefaniak AB, Guilmette RA, Day GA, Hoover MD, Breysse PN, Scripsick RC (2005) Characterization of phagolysosomal simulant fluid for study of beryllium aerosol dissolution. Toxicol In Vitro 19:123–134

    Article  PubMed  CAS  Google Scholar 

  • Stoeckle JD, Hardy HL, Weber AL (1969) Chronic beryllium disease. Long-term follow-up of sixty cases and selective review of the literature. Am J Med 46:545–559

    Article  PubMed  CAS  Google Scholar 

  • Stonehouse AJ, Zenczak S (1991) Properties, production processes, and applications. In: Rossman MD, Preuss O, Powers MB (eds) Beryllium: biomedical and environmental aspects. Williams and Wilkins, Baltimore, pp 27–55

    Google Scholar 

  • Tan MH, Commens CA, Burnett L, Snitch PJ (1996) A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens. Australas J Dermatol 37:185–187

    Article  PubMed  CAS  Google Scholar 

  • Tinkle SS, Newman LS (1997) Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease. Am J Respir Crit Care Med 156:1884–1891

    PubMed  CAS  Google Scholar 

  • Tinkle SS, Antonini JM, Rich BA, Roberts JR, Salmen R, DePree K, Adkins EJ (2003) Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 111:1202–1208

    Article  PubMed  CAS  Google Scholar 

  • Wegner R, Heinrich-Ramm R, Nowak D, Olma K, Poschadel B, Szadkowski D (2000) Lung function, biological monitoring, and biological effect monitoring of gemstone cutters exposed to beryls. Occup Environ Med 57:133–139

    Article  PubMed  CAS  Google Scholar 

  • Weston A, Snyder J, McCanlies EC, Schuler CR, Kreiss K, Demchuk E (2005) Immunogenetic factors in chronic beryllium disease. Mut Res (in press)

Download references

Author information

Authors and Affiliations

  1. Division of Respiratory Disease Studies, National Institute for Occupational Safety and Health, 1095 Willowdale Road, MS 2703, Morgantown, WV, 26505-2888, USA

    Gregory A. Day & Aleksandr B. Stefaniak

  2. Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USA

    Ainsley Weston

  3. Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA

    Sally S. Tinkle

Authors
  1. Gregory A. Day
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aleksandr B. Stefaniak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ainsley Weston
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sally S. Tinkle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregory A. Day.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Day, G.A., Stefaniak, A.B., Weston, A. et al. Beryllium exposure: dermal and immunological considerations. Int Arch Occup Environ Health 79, 161–164 (2006). https://doi.org/10.1007/s00420-005-0024-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00420-005-0024-0

Keywords

Search

Navigation